iQIYI earnings missed by ¥0.11, revenue fell short of estimates

iQIYI (NASDAQ: IQ) reported a wider-than-expected Q2 EPS loss of ¥-0.140, significantly missing analyst estimates of ¥-0.030, and slightly underperformed on revenue at ¥6.63 billion against a ¥6.65 billion consensus. This earnings miss follows five negative EPS revisions in the last 90 days, despite the company maintaining a 'good performance' financial health rating and a 36.53% stock price increase over the last three months, contrasting with a 25.97% decline year-over-year.

Analysis

iQIYI reported a significant second-quarter earnings miss, with an EPS of ¥-0.140 falling substantially short of the ¥-0.030 analyst consensus. This underperformance was accompanied by a marginal revenue miss, with quarterly revenue of ¥6.63 billion versus an expected ¥6.65 billion. The negative result aligns with deteriorating analyst sentiment preceding the report, highlighted by five negative EPS revisions and zero positive revisions over the last 90 days. This fundamental weakness contrasts sharply with the stock's recent technical strength, having gained 36.53% in the last three months. However, the longer-term view remains negative, with the stock down 25.97% over the last 12 months. The designation of its financial health as "good performance" presents a conflicting signal, suggesting underlying balance sheet stability may not be reflected in current operational profitability, a key point of divergence for investors to scrutinize.

Key Decisions for Investors

• Investors should treat the stock's recent 36.53% rally with caution, as the significant EPS miss and trend of negative analyst revisions undermine the fundamental basis for this momentum.
• The conflicting data between poor operational results and a "good performance" financial health score warrants a deeper due diligence on the company's balance sheet and cash flow before initiating or adding to a position.
• Monitor future management guidance on profitability and any reversal in the trend of negative EPS revisions, as these will be critical catalysts determining if the stock can overcome its long-term -25.97% decline.